Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.17 (
MMP-3
)
3,419
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Monoclonal antibodies were raised that specifically recognize the NH2-terminal neoepitope sequence present in
link protein
cleavage products derived from
stromelysin
-degraded proteoglycan aggregate. Competitive enzyme-linked immunosorbent assay, using synthetic peptides as inhibitors, showed that one of these antibodies (CH-3) required, for antibody recognition, the free NH2-terminal amino acid isoleucine (residue 17 of the intact protein) in the sequence NH2-IQAENG at the
stromelysin
cleavage site of
link protein
3. Human proteoglycan aggregate was digested with recombinant human
stromelysin
, bovine chymotrypsin, bovine trypsin, and porcine elastase, and their respective
link protein
degradation products were tested for immunoreactivity with antibody CH-3. Only
stromelysin
- and chymotrypsin-generated
link protein
3 were recognized by antibody CH-3. Both of these enzymes generate
link protein
NH2 termini with the sequence 17IQAENG. . .; hence these studies indicated that monoclonal antibody CH-3 recognized this neoepitope sequence in only specific proteolytically modified
link protein
molecules. Since the occurrence of
link protein
3 increases with aging, the incidence of CH-3 epitope in proteoglycans isolated from human knee articular cartilage of individuals of different ages was investigated. The prevalence of CH-3 epitope was found to be highest in newborn and adolescent articular cartilage samples. However, little CH-3 epitope was detected in older adult cartilage, although considerably more
link protein
3 was present in these samples. These results suggest that additional proteolytic agents are responsible for the increased occurrence of
link protein
degradation products with aging.
...
PMID:Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation. Application to studies of human link protein cleavage by stromelysin. 137 86
Human
cartilage link protein
exists as three native components, while equine, bovine, and porcine
cartilage link protein
exist as two and Swarm rat chondrosarcoma
link protein
exists as only one component. These nonhuman
link protein
components represent intact protein structures, and there is little evidence for proteolytically modified forms in nonhuman tissues. In human cartilage, the proteolytic production of modified link proteins increases with age, whereas high amounts of such products were not seen in the nonhuman tissues. However, the small amounts of
link protein
fragments that were observed in the nonhuman cartilages were of a similar size to their human counterparts. On digestion of human proteoglycan aggregate with
stromelysin
, rapid modification of the
link protein
components occurred, whereas the aggregates from nonhuman cartilages showed incomplete cleavage of their
link protein
components. The relative resistance of nonhuman
link protein
to
stromelysin
may in part be due to a unique amino acid substitution present near the enzymic cleave site.
...
PMID:Link protein shows species variation in its susceptibility to proteolysis. 150 Sep 76
The action of purified rabbit bone
stromelysin
was investigated on proteoglycan aggregates from pig laryngeal cartilage. The enzyme caused a rapid fall in viscosity of proteoglycan aggregate solution (6 mg/ml), and the products of a partial digest (60% loss of relative viscosity) and a complete digest (95% loss of relative viscosity) were characterized. Analysis by gel chromatography on Sepharose 2B under associative conditions showed that 95% of the glycosaminoglycans in the complete digest were in small-sized fragments, whereas most of the hyaluronan-binding G1 domain and
link protein
remained intact and bound to hyaluronan. In contrast, there was extensive digestion of the G2 domain which resulted in 76% loss in its detection by immunoassay. Analysis of the partial digest also showed considerable loss (40%) of detection of the G2 domain, but the glycosaminoglycan-rich fragments were much larger than in the complete digest. There was also much less cleavage to create small fragments containing the G1 domain. This was evident on SDS/PAGE analysis where a 58 kDa G1 domain fragment was abundant in the complete digest, but was only present in small amounts in the partial digest. There was also only very limited conversion of
link protein
from a 44 kDa form to a 40 kDa form. The digestion of proteoglycan aggregate (6 mg/ml) by
stromelysin
was unaffected by the addition of a high concentration of extra chondroitin sulphate chains (14 mg/ml), and the digestion of proteoglycan monomer showed that the G1 domain was resistant to
stromelysin
digestion even when not bound to hyaluronan and
link protein
. The results show that
stromelysin
degrades the proteoglycan protein core with major cleavages close to, but not within, the G1 domain, and extensive cleavage in other regions. Experiments with purified collagenase, a metalloproteinase structurally related to
stromelysin
, showed that it too cleaved proteoglycan at several sites within the glycosaminoglycan-rich region of the core protein. Metalloproteinase attack on proteoglycan thus not only occurs with
stromelysin
but also with collagenase.
...
PMID:Metalloproteinase digestion of cartilage proteoglycan. Pattern of cleavage by stromelysin and susceptibility to collagenase. 165 87
Mild digestion of 125I-labelled human proteoglycan aggregates with trypsin or
stromelysin
produced specific peptides that were taken up rapidly by THP-1 monocytes. SDS/PAGE of undigested aggregate showed that the three components of molecular mass 48, 44 and 41 kDa, corresponding to isoforms of
link protein
originally present, had been converted into a single component of 41 kDa by trypsin treatment, and that fragments of 6-12 kDa were present in fractions containing the high-uptake peptide. Separate proteolysis of isolated proteoglycan monomer and
link protein
confirmed that the specific high-uptake fragment was derived from
link protein
. Uptake of the link fragment was rapid, reaching a maximum after 5 min, and specific, since it was blocked by metabolic or serine proteinase inhibitors and at 4 degrees C. After uptake the cleaved fragment was processed further, with 50% of the radiolabel being released as degraded peptides within 5 min. In contrast, accumulation of whole aggregate reached a maximum after 45 min and only 50% had been released after 2 h. Uptake of aggregate was less affected by inhibitors or at low temperature, suggesting that a separate mechanism existed for its turnover. The aggregate was transported to lysosomes after uptake, although the link fragment did not sediment with either lysosomes or plasma membranes, suggesting that it was present in the cytoplasm or in very labile vesicles. However, the mode of handling of the peptide by the cells remains unclear. The link fragment was taken up by several different monocytic and B cell lines, but not by mouse fibroblasts or peritoneal macrophages. These data suggest that a surface serine proteinase on monocytes and B cells enables them to process and take up a fragment of
link protein
derived by extracellular proteolysis.
...
PMID:A proteolytic fragment from human link protein is taken up and processed by monocytes and B cells. 176 32
The
link protein
components of proteoglycan aggregates in adult human articular cartilage show heterogeneity due to proteolysis. Cleavages near the N-terminus of the intact link proteins, before residues 17, 19 and 24, generate three proteins of slightly diminished size (LP3). Cleavages within the N-terminal disulphide-bonded loop, before residues 66 and 73 of the intact link proteins, generate proteins that yield smaller degradation products upon reduction (LP fragments). In vitro, modified
link protein
components of a similar size to LP3 can be generated by a variety of proteinases, but of the physiologically relevant enzymes only
stromelysin
, cathepsin B and cathepsin G have the ability to yield modified link proteins with N-termini identical with those observed in situ. None of the proteolytic agents tested was able to produce LP fragments with N-termini identical with those observed in situ, and the majority of proteinases were not able to cleave within the disulphide-bonded loops. Cathepsin L and hydroxyl radicals can cleave within the N-terminal disulphide-bonded loop, and have the potential of initially opening the loop to allow further proteolytic processing by other agents to generate the native cleavage sites.
...
PMID:Link protein as a monitor in situ of endogenous proteolysis in adult human articular cartilage. 188 26
Aging of human articular cartilage is associated with proteolytic degradation of its constituent proteoglycan aggregates. Similar events are thought to be associated with proteoglycan loss in osteoarthritis. Degradative changes in
link protein
have been characterized and can be used as an indicator of the causative proteolytic agents. In the neonate, proteolysis results in cleavage of the N-terminal 16 amino acids, at a site characteristic for the metalloproteinase
stromelysin
. In the adult, further cleavage occurs in the N-terminal region and the adjacent disulfide bonded loop, indicating the action of additional proteolytic agents. In osteoarthritis,
link protein
cleavage occurs at sites identical to those observed in the normal adult.
...
PMID:Mechanisms of proteoglycan degradation in human articular cartilage. 202 31
Cartilage proteoglycan aggregates were subjected to degradation by a metalloproteinase, capable of degrading proteoglycan, released from cartilage in culture. This proteinase was demonstrated to be immunologically identical with fibroblast
stromelysin
. An early release of hyaluronic acid-binding region and large glycosaminoglycan-attachment regions was observed. With increasing time the glycosaminoglycan-attachment regions were digested into smaller fragments and the hyaluronic acid-binding regions accumulated. The degradation of link proteins also occurred concomitantly with these events. Link proteins were converted into a component of similar size to that of the smallest native
link protein
component. N-Terminal sequence analysis of the three human
link protein
components indicated that they are all derived from the same protein core, which is closely homologous to that of the rat chondrosarcoma
link protein
. The two larger link proteins (Mr 48,000 and 44,000) contain the same N-terminal sequence, but they differ by the apparent presence of an N-linked oligosaccharide at residue 6 of the largest
link protein
component. The smallest
link protein
(Mr 41,000), however, has an N-terminal sequence equivalent to that commencing at residue 17 in the larger link proteins. It was found that the cartilage metalloproteinase cleaves link proteins in human neonatal cartilage proteoglycan aggregates at the His-16-Ile-17 bond, the same position at which the smallest
link protein
component appears to be derived naturally from the two larger
link protein
components. These results suggest that
stromelysin
secreted by chondrocytes can account for the increased accumulation of hyaluronic acid-binding regions and much of the degradation of
link protein
observed during aging within human articular cartilage.
...
PMID:Degradation of proteoglycan aggregate by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ. 271 51
The actions of human recombinant stromelysins-1 and -2, collagenase, gelatinases A and B and matrilysin on neonatal human proteoglycan aggregates were examined. With the exception of gelatinase B, aggrecan was degraded extensively by most metalloproteinases studied, whereas
link protein
showed only limited proteolysis. Sequencing studies of modified
link protein
components revealed that stromelysins-1 and -2, gelatinases A and B and collagenase cleaved specifically between His16 and Ile17, and matrilysin,
stromelysin
-2 and gelatinase A cleaved between Leu25 and Leu26. Cleavage at the former bond generated a
link protein
component with the same N-terminus as that isolated from newborn human cartilage. Based on previously determined in situ cleavage sites it is evident that matrix metalloproteinases are not solely responsible for the accumulation of
link protein
degradation products in adult human cartilage, indicating that additional proteolytic agents are involved in the normal catabolism of human cartilage matrix.
...
PMID:Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. 769 69
A peptide cleaved from the link-protein component of human and pig proteoglycan aggregates by trypsin and
stromelysin
was taken up and degraded further by human monocytes, B cells, chondrocytes and by mouse peritoneal macrophages. Monocytes were able to process the peptide twice as rapidly as peritoneal macrophages and some 16 times more rapidly than articular chondrocytes. The B cell line Priess, which unlike the monocytes and macrophages could not take up or degrade whole proteoglycan aggregates, was able to degrade the peptide at a rapid rate. Synthetic, unglycosylated peptides consisting of the first 16 and 13 N-terminal amino acids of human
link protein
, corresponding to its
stromelysin
-cleavage and trypsin-cleavage products, were also taken up and degraded in a similar manner to the natural products and, in addition, were able to block uptake of the 125I-labelled natural peptides. The isoelectric points of the re-secreted breakdown fragment from both the synthetic and natural peptides were identical and each peptide was processed by the cells to produce a single radiolabelled fragment. Each of these fragments was eluted with the same retention time during HPLC, indicating that the natural peptides were derived from the N-terminal region of the link. Since a proportion of the
link protein
extracted from human and pig cartilage has already undergone proteolysis to remove peptides from its N-terminal region, these peptides may be produced in articular cartilage during the normal process of turnover and ageing. Although a physiological function for this protein has not been established, it may have a homeostatic role in the regulation of proteoglycan synthesis.
...
PMID:An N-terminal peptide from link protein is rapidly degraded by chondrocytes, monocytes and B cells. 844 67
The peptide DHLSDNYTLDHDRAIH (Link N), cleaved from the N-terminus of the
link protein
component of cartilage proteoglycan aggregates by the action of
stromelysin
, can act as a growth factor and stimulate synthesis of proteoglycans and collagen in articular cartilage [McKenna, Liu, Sansom and Dean (1998) Arthritis Rheum. 41, 157-161]. The mechanism by which this biologically active peptide is degraded and inactivated was investigated using U937 monocytes as a model cell. Time-course experiments showed that two major proteases, an initial serine proteinase followed by a metalloproteinase, acted in sequence. Analysis of the resulting fragments showed that the serine endopeptidase cleavage was at the Leu(3)-Ser(4) bond to produce the peptide SDNYTLDHDRAIH. The terminal serine could then be removed from the resulting peptide by an aminopeptidase. A second metallopeptidase liberated the peptides SDNYTL or DNYTL from DHDRAIH by cleavage at the Leu(9)-Asp(10) bond. The DNYTL peptide intermediate was degraded too rapidly to allow sequencing and sequential aminopeptidase cleavages removed further amino acids from the N-terminus of the remaining DHDRAIH peptide. The identical patterns of breakdown that occurred when either whole cells or purified plasma membranes were used indicated that proteolysis and inactivation of Link N was carried out entirely by membrane-associated enzymes.
...
PMID:Link peptide cartilage growth factor is degraded by membrane proteinases. 1088 Mar 46
1
2
Next >>